Sabra director awarded 817 stock units

Kono Ann reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kono Ann reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. director Ann Kono received an award of 817 common stock units on May 29, 2026. These units were credited as dividend equivalent payments on previously granted stock units under the company’s 2009 Performance Incentive Plan and carry no purchase price.

Each stock unit represents the right to receive one share of common stock and will vest and be paid on the same schedule as the original awards. Following this grant, Kono directly holds 59,876 stock units, including 726 unvested units and 54,290 vested units for which payment has been deferred.

Insider Trade Summary

Grant/Award: 817 shares

Grant/Award 1 txn

Insider Kono Ann

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	817	$0.00	$0.00

Holdings After Transaction: Common Stock — 59,876 shares (Direct)

Footnotes (2)

1. F1. Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.
2. F2. Includes 726 unvested stock units and 54,290 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Key Figures

Stock units granted: 817 stock units Holdings after transaction: 59,876 stock units Unvested stock units: 726 stock units +2 more

5 metrics

Stock units granted 817 stock units Grant on May 29, 2026 as dividend equivalent payments

Holdings after transaction 59,876 stock units Total stock units directly held by Ann Kono after grant

Unvested stock units 726 stock units Unvested units included in Kono’s total stock unit holdings

Vested but deferred units 54,290 stock units Vested units with payment deferred to a future date

Transaction price $0.0000 per share Indicates no cash was paid for the granted stock units

Key Terms

stock units, dividend equivalent payments, 2009 Performance Incentive Plan, vested but the payment of which has been deferred, +1 more

5 terms

stock units financial

"Represents stock units credited to the reporting person in the form of dividend equivalent payments"

Stock units are individual pieces of ownership in a company, like slices of a pie that together make up the whole business. They matter to investors because each unit represents a claim on the company’s assets, profits and sometimes voting power, and changes in the number or value of these units affect ownership percentages, potential dividends and share dilution — all of which influence an investment’s worth.

dividend equivalent payments financial

"credited to the reporting person in the form of dividend equivalent payments on stock units previously granted"

2009 Performance Incentive Plan financial

"outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value"

vested but the payment of which has been deferred financial

"54,290 stock units that have vested but the payment of which has been deferred"

right to receive one share financial

"Each stock unit represents the right to receive one share of the Issuer's Common Stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Sabra Health Care REIT (SBRA) report about Ann Kono in this Form 4?

Sabra Health Care REIT reported that director Ann Kono received 817 common stock units as a grant on May 29, 2026. The award represents dividend equivalent payments tied to earlier stock unit grants under the 2009 Performance Incentive Plan, with no cash purchase involved.

How many Sabra Health Care REIT (SBRA) stock units does Ann Kono hold after this transaction?

After the transaction, Ann Kono holds 59,876 Sabra Health Care REIT stock units directly. This total includes 726 unvested stock units and 54,290 stock units that have already vested but whose payment has been deferred to a future date under plan terms.

Was there any cash paid for the Sabra Health Care REIT (SBRA) stock units granted to Ann Kono?

No cash was paid for these stock units; the transaction price per share is reported as 0.0000. The 817 units were credited as dividend equivalent payments on existing stock units, reflecting reinvested value rather than an open-market purchase.

What is the nature of the 817 Sabra Health Care REIT (SBRA) stock units granted to Ann Kono?

The 817 stock units are dividend equivalent payments on previously granted stock units under the 2009 Performance Incentive Plan. They will vest and become payable on the same terms and schedule as the original related stock unit awards, aligning compensation with prior grants.

How are Sabra Health Care REIT (SBRA) stock units described in Ann Kono’s Form 4 filing?

Each stock unit in the filing represents the right to receive one share of Sabra Health Care REIT common stock. Some units are unvested, while 54,290 units have vested but their payment has been deferred, indicating future delivery rather than immediate share issuance.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 03:14 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kono Ann

(Last) (First) (Middle)

C/O SABRA HEALTH CARE REIT, INC.

1781 FLIGHT WAY

(Street)

TUSTIN CALIFORNIA 92782

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/29/2026		A		817(1)	A	$0	59,876(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents stock units credited to the reporting person in the form of dividend equivalent payments on stock units previously granted to the reporting person that are outstanding under the Issuer's 2009 Performance Incentive Plan, calculated on the basis of the market value of the Issuer's common stock on the dividend payment date. These units will vest and become payable on the same terms as the original stock units to which they relate.

2. Includes 726 unvested stock units and 54,290 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Remarks:

	/s/ Michael Costa, as Attorney-in-Fact	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)